4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-18-000003
Chief Operating Officer gave up 2,815 shares (to pay taxes)
- Chief Operating Officer acquired 8,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sardesai Niranjan · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-05 | Exercise or conversion : show line 1 in the form | +8,333 | 93,416 | D | ||
| 2018-03-05 | Shares withheld for taxes : show line 2 in the form | −2,815 | $4.29 | $12,076 | 90,601 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-03-05 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −8,333 | 8,333 | 0 | D | ||
| 2018-03-05 | Grant or award : show line 4 in the form Common Stock Option | +126,500 | $4.29 | 2028-03-05 | 126,500 | 126,500 | D |
| 2018-03-05 | Grant or award : show line 5 in the form Restricted Stock Unit | +82,700 | 82,700 | 82,700 | D |
Loading xslF345X03/wf-form4_152046971988104.xml…